[go: up one dir, main page]

NO161674C - Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater. - Google Patents

Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.

Info

Publication number
NO161674C
NO161674C NO830110A NO830110A NO161674C NO 161674 C NO161674 C NO 161674C NO 830110 A NO830110 A NO 830110A NO 830110 A NO830110 A NO 830110A NO 161674 C NO161674 C NO 161674C
Authority
NO
Norway
Prior art keywords
triazolo
preparation
derivatives
tthalazine
substituted
Prior art date
Application number
NO830110A
Other languages
English (en)
Other versions
NO161674B (no
NO830110L (no
Inventor
Domenico Barone
Giorgio Tarzia
Emilio Occelli
Adele Giunta
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO830110L publication Critical patent/NO830110L/no
Publication of NO161674B publication Critical patent/NO161674B/no
Publication of NO161674C publication Critical patent/NO161674C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO830110A 1982-01-18 1983-01-14 Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater. NO161674C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18

Publications (3)

Publication Number Publication Date
NO830110L NO830110L (no) 1983-07-19
NO161674B NO161674B (no) 1989-06-05
NO161674C true NO161674C (no) 1989-09-13

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830110A NO161674C (no) 1982-01-18 1983-01-14 Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.

Country Status (20)

Country Link
US (1) US4788186A (no)
EP (1) EP0085840B1 (no)
JP (1) JPS58124786A (no)
KR (1) KR890000184B1 (no)
AT (1) ATE22562T1 (no)
AU (1) AU564026B2 (no)
CA (1) CA1214168A (no)
DE (1) DE3366494D1 (no)
DK (1) DK163145C (no)
ES (1) ES8601995A1 (no)
FI (1) FI81350C (no)
GR (1) GR78442B (no)
HU (1) HU193033B (no)
IE (1) IE55032B1 (no)
IL (1) IL67697A (no)
NO (1) NO161674C (no)
NZ (1) NZ203021A (no)
PH (1) PH21834A (no)
PT (1) PT76107A (no)
ZA (1) ZA83224B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (it) * 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
JP2000515851A (ja) 1996-07-25 2000-11-28 メルク シヤープ エンド ドーム リミテツド GABA▲下Aα5▼レセプターサブタイプの逆アゴニストとしての置換のあるトリアゾロピリダジン誘導体
TR199900047T2 (xx) * 1996-07-25 1999-03-22 Merck Sharp & Dohme Limited Gaba resept�rleri ligandlar� olarak ikame triazolo-piridazin t�revleri
JP4672820B2 (ja) 1997-05-08 2011-04-20 メルク シャープ エンド ドーム リミテッド GABAα5リガンドとしての置換1,2,4−トリアゾロ[3,4−a]フタラジン誘導体
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
ES2137113B1 (es) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa Nuevos derivados de triazolo-piridazinas heterociclicos.
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
AU746866B2 (en) 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
CZ290883B6 (cs) 1998-01-21 2002-11-13 Merck Sharp And Dohme Limited Triazolopyridazinové deriváty, způsob jejich výroby a farmaceutický prostředek je obsahující
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
EA002824B1 (ru) * 1998-02-25 2002-10-31 Мерк Шарп Энд Домэ Лимитед ЗАМЕЩЕННЫЙ 1,2,4-ТРИАЗОЛО[3,4-а]ПИРИДАЗИН
IL137117A0 (en) 1998-02-25 2001-06-14 Merck Sharp & Dohme Substituted 1,2,4-triazolo [3,4-a] pyridazine
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
WO2000027849A2 (en) 1998-11-12 2000-05-18 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
JP2004527531A (ja) * 2001-04-10 2004-09-09 メルク エンド カムパニー インコーポレーテッド 癌を治療する方法
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
US20060142178A1 (en) * 2002-04-08 2006-06-29 Barnett Stanley F Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
CN101133057B (zh) * 2004-09-02 2011-03-09 尼科梅德有限责任公司 三唑并酞嗪化合物
EA012505B1 (ru) * 2005-01-05 2009-10-30 Никомед Гмбх Триазолофталазины в качестве ингибиторов pde-2
JP5130053B2 (ja) * 2005-01-05 2013-01-30 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング トリアゾロフタラジン
PH12012501361A1 (en) 2009-12-31 2012-10-22 Centro Nac De Investigaciones Oncologicas Cnio Tricyclic compounds for use as kinase inhibitors
CN103694244B (zh) * 2014-01-09 2016-03-30 郑州大学 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途
CN104016986B (zh) * 2014-03-13 2016-02-03 郑州大学 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (ja) * 1976-08-10 1985-01-25 三菱化学株式会社 S―トリアゾロ〔3,4 ―α〕〔5,6,7,8〕テトラヒドロ フタラジン類
GR70309B (no) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
GR78442B (no) 1984-09-27
IL67697A (en) 1990-02-09
FI81350C (fi) 1990-10-10
DE3366494D1 (de) 1986-11-06
DK163145C (da) 1992-06-22
DK17983D0 (da) 1983-01-18
IE830082L (en) 1983-07-18
JPS58124786A (ja) 1983-07-25
ES531458A0 (es) 1985-11-01
CA1214168A (en) 1986-11-18
PH21834A (en) 1988-03-17
FI81350B (fi) 1990-06-29
DK17983A (da) 1983-07-19
ZA83224B (en) 1983-10-26
EP0085840B1 (en) 1986-10-01
AU564026B2 (en) 1987-07-30
EP0085840A1 (en) 1983-08-17
NO161674B (no) 1989-06-05
KR840003254A (ko) 1984-08-20
ES8601995A1 (es) 1985-11-01
AU1055083A (en) 1983-07-28
IE55032B1 (en) 1990-05-09
IL67697A0 (en) 1983-05-15
DK163145B (da) 1992-01-27
US4788186A (en) 1988-11-29
PT76107A (en) 1983-02-01
NO830110L (no) 1983-07-19
NZ203021A (en) 1986-05-09
JPH048428B2 (no) 1992-02-17
HU193033B (en) 1987-08-28
ATE22562T1 (de) 1986-10-15
FI830100L (fi) 1983-07-19
FI830100A0 (fi) 1983-01-12
KR890000184B1 (ko) 1989-03-09

Similar Documents

Publication Publication Date Title
NO161674C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO152215C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO160001C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO159590C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive fenyleddiksyre-derivater.
NO161258C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive 1-pyridyloksy-3-indolylalkylamino-2-propanol-derivater.
NO160139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive akridanonderivater.